Multiple Myeloma, Hyperviscosity, Hemodialysis Filter Clogging, and Antigen Excess Artifact: A Case Report

Kanduri, Swetha R; LeDoux, Jason R.; Kovvuru, Karthik; Wu, Qingli

doi:10.1016/j.xkme.2021.02.011

Cited by 1 publication

(1 citation statement)

References 20 publications

(55 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clogging refers to an isolated reduction of filter transmembrane patency, mediated through molecules covering the filter surface and thereby obstructing the pores, but not the capillary per se. Hyperlipidemia, activated coagulation, systemic inflammation and elevated blood viscosity secondary to increased levels of proteins have all been suspected as potential contributing factors [6][7][8][9][10][11]. First of all, clogging leads to a progressive loss of dialysis efficacy.…”

Section: Introductionmentioning

confidence: 99%

Metabolic disturbances potentially attributable to clogging during continuous renal replacement therapy

Müller,

Caspar,

Sazpinar

et al. 2023

ICMx

View full text Add to dashboard Cite

Background Clogging is characterized by a progressive impairment of transmembrane patency in renal replacement devices and occurs due to obstruction of pores by unknown molecules. If citrate-based anti-coagulation is used, clogging can manifest as a metabolic alkalosis accompanied by hypernatremia and hypercalcemia, primarily a consequence of Na3Citrate infusion. An increased incidence of clogging has been observed during the COVID-19 pandemic. However, precise factors contributing to the formation remain uncertain. This investigation aimed to analyze its incidence and assessed time-varying trajectories of associated factors in critically ill patients on continuous renal replacement therapy (CRRT). Methods In this retrospective, single-center data analysis, we evaluated COVID-19 patients undergoing CRRT and admitted to critical care between March 2020 and December 2021. We assessed the proportional incidence of clogging surrogates in the overall population and subgroups based on the specific CRRT devices employed at our institution, including multiFiltrate (Fresenius Medical Care) and Prismaflex System (Baxter). Moderate and severe clogging were defined as Na > 145 or ≥ 150 mmol/l and HCO3− > 28.0 or ≥ 30 mmol/l, respectively, with a total albumin-corrected calcium > 2.54 mmol/l. A mixed effect model was introduced to investigate factors associated with development of clogging. Results Fifty-three patients with 240 CRRT runs were analyzed. Moderate and severe clogging occurred in 15% (8/53) and 19% (10/53) of patients, respectively. Twenty-seven percent (37/136) of CRRTs conducted with a multiFiltrate device met the criteria for clogging, whereas no clogging could be observed in patients dialyzed with the Prismaflex System. Occurrence of clogging was associated with elevated triglyceride plasma levels at filter start (p = 0.013), amount of enteral nutrition (p = 0.002) and an increasing white blood cell count over time (p = 0.002). Conclusions Clogging seems to be a frequently observed phenomenon in critically ill COVID-19 patients. The presence of hypertriglyceridemia, combined with systemic inflammation, may facilitate the development of an impermeable secondary membrane within filters, thereby contributing to compromised membrane patency.

show abstract